Behar-Cohen F - Search Results

1

Sustained-release steroids for the treatment of diabetic macular edema.

Daruich A, Matet A, Behar-Cohen F. Daruich A, et al. Curr Diab Rep. 2015 Nov;15(11):99. doi: 10.1007/s11892-015-0669-3. Curr Diab Rep. 2015. PMID: 26395924 Free article. Review.

2

Early effects of intravitreal triamcinolone on macular edema: mechanistic implication.

Miyamoto N, Iossifov D, Metge F, Behar-Cohen F. Miyamoto N, et al. Ophthalmology. 2006 Nov;113(11):2048-53. doi: 10.1016/j.ophtha.2006.05.037. Epub 2006 Aug 28. Ophthalmology. 2006. PMID: 16935337

3

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Daruich A, et al. Prog Retin Eye Res. 2015 Sep;48:82-118. doi: 10.1016/j.preteyeres.2015.05.003. Epub 2015 May 27. Prog Retin Eye Res. 2015. PMID: 26026923 Free article. Review.

4

Corticosteroids and the retina: a role for the mineralocorticoid receptor.

Behar-Cohen F, Zhao M. Behar-Cohen F, et al. Curr Opin Neurol. 2016 Feb;29(1):49-54. doi: 10.1097/WCO.0000000000000284. Curr Opin Neurol. 2016. PMID: 26679569 Review.

5

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, Behar-Cohen F. Daruich A, et al. Transl Vis Sci Technol. 2016 Mar 4;5(2):2. doi: 10.1167/tvst.5.2.2. eCollection 2016 Mar. Transl Vis Sci Technol. 2016. PMID: 26966638 Free PMC article.

6

Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography.

Matet A, Daruich A, Dirani A, Ambresin A, Behar-Cohen F. Matet A, et al. Am J Ophthalmol. 2016 Jul;167:18-30. doi: 10.1016/j.ajo.2016.04.005. Epub 2016 Apr 12. Am J Ophthalmol. 2016. PMID: 27084003

7

VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2.

Spaide RF, Suzuki M, Yannuzzi LA, Matet A, Behar-Cohen F. Spaide RF, et al. Retina. 2017 Mar;37(3):424-435. doi: 10.1097/IAE.0000000000001344. Retina. 2017. PMID: 27749698

8

Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.

Daruich A, Parcq J, Delaunay K, Naud MC, Le Rouzic Q, Picard E, Crisanti P, Vivien D, Berdugo M, Behar-Cohen F. Daruich A, et al. Mol Vis. 2016 Nov 10;22:1332-1341. eCollection 2016. Mol Vis. 2016. PMID: 27881907 Free PMC article.

9

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, Spaide RF, Turck N, Behar-Cohen F. Kowalczuk L, et al. Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424. Retina. 2017. PMID: 28002269 Free PMC article.

10

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.

Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F. Daruich A, et al. Retina. 2017 Oct;37(10):1905-1915. doi: 10.1097/IAE.0000000000001443. Retina. 2017. PMID: 28067724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters